Europe Blood Culture Tests Market

Europe Blood Culture Tests Market Size (2024 to 2029)

The size of the Europe Blood Culture Tests market is anticipated to grow at 8.80% CAGR from 2024 to 2029. It is estimated that the European market was valued at USD 16.31 billion in 2024 and is expected to reach USD 24.86 billion by 2029. The availability of advanced diagnostics products and the presence of highly developed healthcare infrastructure in the European countries like Germany, the UK, Switzerland, and France have further fueled the growth of the European blood culture tests market. Also, growing investments in R&D by manufacturers for new product development in this region is expected to propel the growth of the industry. Furthermore, increasing R & D investments by manufacturers for new product development in this region is expected to drive the growth of the industry.

Furthermore, the increasing number of patients and growing prevalence for the hospitals due to increasing COVID-19 cases in the European countries are fuelling the market growth in blood culture tests. Extensive usage of blood culture tests in hospitals labs, reference labs, and other purposes are propelling the market future. Growing product acceptances and launches are likely to fuel the blood culture tests market. With high growth in death rate and illness, the requirement for diagnostic procedures will accelerate the growth. According to WHO, thirty million people are affected by sepsis and tend to 6 million deaths every year. High expenditure by singles towards the healthcare and existence of strong medical healthcare is boosting the market.

The expensive nature of the highly automated blood testing lab instruments for productive diagnosis and regular approval procedures in the region are expected to impede the growth. However, a deficit of knowledge on technology's latest advancements is restraining the market’s growth rate. Lack of experienced lab technicians is restricting the market growth of blood culture over the period. Strict government guidelines for the enhancement and manufacturing of the diagnosis of products, including blood culture test products, hinder the market growth in the region.

This research report on the European Blood Culture Tests Market has been segmented & sub-segmented into the following categories.

Europe Blood Culture Tests Market Analysis By Product

• Consumables
  • Blood Culture Media    
    • Aerobic Blood Culture Media
    • Pediatric Aerobic Blood Culture Media
    • Anaerobic Blood Culture Media
    • Mycobacterial Blood Culture Media
    • Fungi Blood Culture Media
  • Assay Kits & Reagents   
  • Blood Culture Accessories
• Instruments
  • Automated Blood Culture Systems      
  • Supporting Laboratory Equipment       
    • Incubators
    • Colony Counters
    • Microscopes
    • Gram Stainers
• Software and Services

Europe Blood Culture Tests Market Analysis By Technology

• Culture-Based Technology
• Molecular Technologies
  • Microarrays
  • PCR (Polymerase Chain Reaction)       
  • PNA-FiSH (Peptide Nucleic Acid – Fluorescent in Situ Hybridization)       
• Proteomics Technology     

Europe Blood Culture Tests Market Analysis By Application

• Bacteremia
• Fungemia
• Mycobacterial Detection

Europe Blood Culture Tests Market Analysis By End User

• Hospital Laboratories
• Reference Laboratories

Europe Blood Culture Tests Market Analysis By Country

• United Kingdom
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Rest of Europe

Regional Analysis

Europe is just behind North America in leading the majority share in the global blood culture tests market and is expected to have flourishing growth in the coming years. The rise in the occurrence of diseases like bloodstream infections, kidney disorders, and other organ infections is likely to drive the market growth. The rising older people population and escalating stipulation for the blood culture tests are expected to boost the growth. Germany is leading the market with the highest CAGR of 4.4% in the European region. The country has got prominent growth in the area due to primarily enhanced healthcare infrastructure and the increasing pharmaceutical industry. Investments made by prominent key players in healthcare in research and development activities for new product development and integration of technological advancements among the medical devices is likely to bolster the growth in the market. Other countries like the UK, France, and Switzerland are expected to strengthen the market higher in the upcoming future.  

The European blood culture tests market is dominated by companies like Becton, Dickinson, and Company, bioMérieux SA, Thermo Fisher Scientific Inc., Cepheid, Inc., Nanosphere Inc., IRIDICA, Beckman Coulter, Bruker Corporation, and T2 Biosystems.